Clinical Trials Browser

Phase 2 × OTHER_GOV × atezolizumab × Clear all

NCT03756298 2023-11-09

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Phase 2 Active not recruiting

Triple Negative Breast Neoplasms

NCT03262454 2022-04-06

Atezolizumab

Phase 2 Unknown

Small Cell Lung Cancer Recurrent